The Type 2 Inflammation Preceptorship, hosting Sanofi Company, was held on November 28th, 2025 at Alfaisal University. The event brought together leading experts in Allergy-Immunology, ENT, and Pulmonology for a collaborative day of scientific learning and clinical skill-building.
The event opened with Dr. Naif AlOtaibi, who set the stage for a full-day program focused on advancing excellence in Type 2 inflammation care.
Key guest faculty included:
- Dr. De Corso Eugenio
- Dr. Rand Arnaout
- Dr. Mohammed Zeitouni
- Dr. Naif AlOtaibi
The morning sessions featured Dr. Rand Arnaout discussing the Role of Type 2 Inflammation in Multi-Morbid Diseases, followed by a dynamic multidisciplinary design sprint led by the full faculty team: Dr. De Corso, Dr. Arnaout, Dr. Zeitouni, and Dr. AlOtaibi.
Panel discussions led by Dr. Rand Arnaout, Dr. Mohammed Zeitouni, and Dr. Naif AlOtaibi explored how pulmonology and ENT integration can elevate multidisciplinary care.
Later in the day, Dr. De Corso presented best practices in comorbidity management and delivered an insightful session on translating cytokine science into clinical outcomes.
Interactive case discussions around biologic therapies in COPD, asthma, and CRSwNP further enriched the learning experience.
The hands-on diagnostic workshops, facilitated by Dr. Naif AlOtaibi, Dr. Rand Arnaout, Dr. Mohammed Zeitouni, and Dr. Musaab, provided practical experience in:
- Smell testing
- Spirometry and pulmonary function
- FeNO testing
- Allergy, Skin Prick testings
The program concluded with closing remarks, and an elegant gala dinner at the Hilton Olaya Hotel.
The event successfully fostered collaboration, shared expertise, and strengthened clinical excellence in the management of Type 2 inflammation.
